Synthesis of New inhibitors of the FibrillogenesisAß42: Alzheimer’s Disease

Journal Title: UNKNOWN - Year 2018, Vol 2, Issue 4

Abstract

Background: The Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common cause of dementia. The pathological hallmarks of AD are the presence of neurofibrillary tangles and amyloid deposits in the brain of the patient, as already defined by Alois Alzheimer in 1907. The aim of our study is to inhibit the formation the folding of amyloid protein by new synthesis of b-sheet breaker peptides. Methods: Our approach consist to develop b-sheet breaker peptides as a novel strategy to inhibit and reverse amyloidosis in AD. The synthesis was down by peptid coupling method. Results: Several b-sheet breaker peptides have been designed based on the hypothesis that amyloid deposition could be inhibited by short synthetic peptides partially homologous to the Ab region undergoing conformational changes to give rise to the amyloidogenic Ab intermediate and containing residues disrupting as aziridine and CD for the b-sheet formation university Tlemcen 2017. Conclusion:At present, there is no ideal drug for the treatment of AD, and the searches for AD drugs remain an urgent issue in the pharmaceutical community. Due to its complex pathogenesis, a single target drug cannot cure this disease fundamentally. Dual or multiple target drugs involved in two or more aspects of AD pathogenesis may generate a synergistic effect and ultimately achieve an ideal therapeutic effect.

Authors and Affiliations

Assia Keniche

Keywords

Related Articles

Composite Morphometric/Morphographic Ultrasound Parameters of the Second Trimester Cervix for the Prediction of Spontaneous Preterm Labor

BACKGROUNDThere is need for simple, cheap and highly predctive test for spontaneous preterm labor (SPL). The"zone of endocervical crypts (ZEC)" is a well-defined sonographic landmark corresponding toenfolding of the endo...

Development of new antibacterial agents

Background: Antibiotics, as miraculous drugs, have been used extensively to confront fatal infection, even without prescriptions. However, the inappropriate and disproportionate use of antibiotics have led to the emergen...

Synthesis of New inhibitors of the FibrillogenesisAß42: Alzheimer’s Disease

Background: The Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common cause of dementia. The pathological hallmarks of AD are the presence of neurofibrillary tangles and amyloid deposit...

Polymorphism rs3087243 is associated with the occurrence of ankylosing spondylitis in the West Algerian population

Background: Numerous studies have shown that polymorphism rs231775 of the CTLA4 gene is strongly implicated in the development of ankylosing spondylitis (AS). Other polymorphisms of this gene are candidates that may have...

Quantitative Analysis in Multimodality Imaging: Challenges and Opportunities

This talk reflects the tremendous ongoing interest in molecular and dual-modality imaging (PET/CT, SPECT/CT and PET/MR) as both clinical and research imaging modalities in the past decade. An overview of molecular multi-...

Download PDF file
  • EP ID EP648938
  • DOI 10.26415/2572-004X-vol2iss4p315-315
  • Views 42
  • Downloads 0

How To Cite

Assia Keniche (2018). Synthesis of New inhibitors of the FibrillogenesisAß42: Alzheimer’s Disease. UNKNOWN, 2(4), 315-315. https://europub.co.uk/articles/-A-648938